Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coordinated immune-epithelial dynamics in the nasal epithelium protect against respiratory virus infection.

bioRxiv : the preprint server for biology·2026
Same author

Reactive and therapy induced bone marrow changes linked to systemic infectious and non-infectious disorders including MAS/HLH report from the European association for haematopathology, Dubrovnik 2024.

Virchows Archiv : an international journal of pathology·2026
Same author

Severe cerebellitis as a manifestation of infliximab-associated overlap of neurosarcoidosis and myelin oligodendrocyte glycoprotein antibody-associated disease - case report.

Frontiers in immunology·2026
Same author

Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

Blood advances·2026
Same author

Mast Cells in Acute COVID-19 Patients.

Allergy·2026
Same author

The genetic landscape of extramedullary plasmacytoma: a comparative analysis with extramedullary disease of multiple myeloma.

Haematologica·2026

Related Experiment Video

Updated: Apr 6, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K

Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report.

Gregor Hutter1, Silvia Hofer, Alexandar Tzankov

  • 1Divisions of *Neurosurgery and ‡Oncology, Luzerner Kantonsspital, Luzern, Switzerland; §Pathology Department, Universitätsspital Basel, Basel, Switzerland; ¶Division of Neurosurgery, University of Basel, Basel, Switzerland.

Neurosurgery
|August 4, 2015
PubMed
Summary
This summary is machine-generated.

This report details the first case of an intracranial interdigitating dendritic cell sarcoma (IDCS), a rare tumor. Complete surgical removal led to full recovery, with no recurrence after 1.5 years.

More Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.7K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.5K

Related Experiment Videos

Last Updated: Apr 6, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.7K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.5K

Area of Science:

  • Neuro-oncology
  • Surgical Pathology

Background:

  • Interdigitating dendritic cell sarcoma (IDCS) are rare neoplasms.
  • Intracranial IDCS have not been previously reported in medical literature.

Observation:

  • A 39-year-old patient presented with right hemiparesis due to a large parafalcine tumor.
  • Histopathological examination confirmed the diagnosis of IDCS.
  • No evidence of extracranial disease was found during staging.

Findings:

  • Complete resection of the intracranial IDCS was achieved.
  • The patient experienced a full recovery of neurological symptoms.
  • The patient remains recurrence-free 1.5 years post-surgery.

Implications:

  • This case establishes intracranial IDCS as a distinct clinical entity.
  • Complete surgical resection is the recommended management strategy.
  • Long-term oncological surveillance is crucial for patients with IDCS.